FDA grants priority review to Roche’s Tecentriq monotherapy as first-line treatment of certain people with advanced non-small cell lung cancer

    NEXT STORY
    Ophthalmic Diagnostic Devices Market to Reach USD 3.86 Billion by 2026; Increasing Prevalence of Ocular Disorders to Boost Growth: Fortune Business Insights™
    PREV STORY
    Teleflex to Present at the Raymond James 41st Annual Institutional Investors Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cellectar Biosciences Reports Cohort Four Data and Partial Response in Relapsed or Refractory Multiple Myeloma Patient Treated with CLR 131

    MADISON, Wis., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, ...

    author_avatar
    NASDAQ Market News

    Checkpoint Therapeutics Reports First Quarter 2019 Financial Results and Recent Corporate Highlights

    author_avatar
    NASDAQ Market News

    Global Colonoscopy Devices Market Will Reach USD 2.41 Billion By 2025: Zion Market Research

    author_avatar
    NASDAQ Market News